| Q46243690 | A 'DNA replication' signature of progression and negative outcome in colorectal cancer |
| Q27936478 | A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size |
| Q34551716 | A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. |
| Q24540211 | A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex. |
| Q51890887 | A role for Myc in facilitating transcription activation by E2F1. |
| Q34982826 | A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites |
| Q24306542 | A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants |
| Q30855570 | Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China |
| Q40618406 | Activated eIF4E-binding Protein Slows G1 Progression and Blocks Transformation by c-myc without Inhibiting Cell Growth |
| Q47259237 | Analysis of genomic targets reveals complex functions of MYC. |
| Q41983730 | Analyzing Myc in cell transformation and evolution |
| Q36092148 | Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter |
| Q48419457 | Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas |
| Q35310856 | Autoregulatory suppression of c-Myc by miR-185-3p |
| Q62817748 | B Cell Growth Is Controlled by Phosphatidylinosotol 3-Kinase-Dependent Induction of Rel/NF-κB Regulated c-myc Transcription |
| Q35082715 | Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc |
| Q42315515 | Calcium-dependent binding of Myc to calmodulin. |
| Q38295703 | Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation |
| Q30834866 | Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes |
| Q28184455 | Characterization of the murine Nramp1 promoter: requirements for transactivation by Miz-1 |
| Q36145215 | Clinical features of molecular pathology of solid tumours in childhood |
| Q35906074 | Connecting proliferation and apoptosis in development and disease |
| Q34605526 | Contributions of Myc to tumorigenesis |
| Q82616798 | Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis |
| Q31031668 | Deciphering c-MYC-regulated genes in two distinct tissues. |
| Q28589097 | Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis |
| Q38348098 | DeltaNp73 can modulate the expression of various genes in a p53-independent fashion |
| Q42491680 | Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis |
| Q35941628 | Deregulation of the cell cycle by the Epstein-Barr virus |
| Q92354388 | Differential regulation of myc homologs by Wnt/β-Catenin signaling in the early metazoan Hydra |
| Q28238796 | Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation |
| Q40677362 | Direct activation of RNA polymerase III transcription by c-Myc |
| Q34803825 | Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells |
| Q34026482 | Disentangling the MYC web. |
| Q33689817 | Distinct and temporal roles of nucleosomal remodeling and histone deacetylation in the repression of the hTERT gene |
| Q35185681 | Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription |
| Q40743661 | Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens |
| Q40612870 | E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. |
| Q44220811 | E2F proteins regulate MYCN expression in neuroblastomas |
| Q28216519 | E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression |
| Q24669890 | Epstein-Barr virus and Burkitt lymphoma |
| Q40543160 | Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc |
| Q31152796 | Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis |
| Q24804513 | FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression |
| Q35885872 | Functions of myc:max in the control of cell proliferation and tumorigenesis |
| Q30886084 | Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc |
| Q35026963 | Genetic reporter system for oncogenic Igh-Myc translocations in mice. |
| Q52670682 | Genomic binding and transcriptional regulation by the Drosophila Myc and Mnt transcription factors. |
| Q35965143 | Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network |
| Q33323393 | Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo |
| Q33705004 | HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. |
| Q24310037 | HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity |
| Q37082118 | Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity |
| Q31013236 | Histone deacetylase activity is necessary for left-right patterning during vertebrate development |
| Q51595537 | Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes. |
| Q33612813 | Hydra myc2, a unique pre-bilaterian member of the myc gene family, is activated in cell proliferation and gametogenesis |
| Q24681460 | Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 |
| Q35669176 | Identification of cis-Regulatory Elements in the dmyc Gene of Drosophila Melanogaster |
| Q40569139 | Identification of genes that are regulated transcriptionally by Myc in childhood tumors |
| Q38363958 | Identifying genes regulated in a Myc-dependent manner |
| Q38306562 | In vitro embryonic developmental phosphorylation of the cellular nucleic acid binding protein by cAMP-dependent protein kinase, and its relevance for biochemical activities |
| Q34619131 | In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential. |
| Q28571341 | Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis |
| Q35043420 | Induction of apoptosis in cancer: new therapeutic opportunities |
| Q37153674 | Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1). |
| Q28656132 | Inhibitor of MYC identified in a Kröhnke pyridine library |
| Q28247124 | Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes |
| Q62839089 | Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis |
| Q41981890 | Integration of Insulin receptor/Foxo signaling and dMyc activity during muscle growth regulates body size in Drosophila |
| Q34989577 | Intracellular glycosylation and development |
| Q34564825 | Invited review: Effects of heat and cold stress on mammalian gene expression |
| Q33949883 | JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis |
| Q64083382 | LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR |
| Q33382271 | Learning transcriptional regulatory networks from high throughput gene expression data using continuous three-way mutual information |
| Q63407030 | Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma |
| Q39647656 | Loss of p27(Kip1) but not p21(Cip1) decreases survival and synergizes with MYC in murine lymphomagenesis |
| Q35056472 | Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals |
| Q37485846 | MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation |
| Q36819401 | MAP kinases and the control of nuclear events |
| Q28250940 | MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer |
| Q51023212 | MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer. |
| Q38193043 | MYC degradation |
| Q39242259 | MYC expression and distribution in normal mature lymphoid cells. |
| Q35149681 | MYC regulates the non-coding transcriptome. |
| Q34288613 | MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer |
| Q39149130 | MYC: Master Regulator of Immune Privilege |
| Q24535514 | Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc |
| Q35096127 | Mammalian neural stem-cell renewal: nature versus nurture |
| Q34230052 | Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo |
| Q33812198 | MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation |
| Q42004179 | MicroRNA: Biogenesis, Function and Role in Cancer |
| Q35199251 | Miz-1 activates gene expression via a novel consensus DNA binding motif |
| Q36321695 | Mnt-Max to Myc-Max complex switching regulates cell cycle entry |
| Q31127154 | Molecular features of adult mouse small intestinal epithelial progenitors |
| Q24300934 | Multiple Wnt/ß-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops |
| Q33248957 | Mutations in PIK3CA are infrequent in neuroblastoma |
| Q39776556 | Mutual interference of adenovirus infection and myc expression |
| Q41831140 | Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas. |
| Q34074572 | Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo |
| Q40495521 | Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway |
| Q34827156 | Myc degradation: dancing with ubiquitin ligases. |
| Q34766868 | Myc influences global chromatin structure. |
| Q41354231 | Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest |
| Q39688916 | Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency |
| Q30480348 | Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1 |
| Q24557458 | Myc represses transcription through recruitment of DNA methyltransferase corepressor |
| Q36149282 | Myc stimulates B lymphocyte differentiation and amplifies calcium signaling |
| Q38324237 | Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis |
| Q38290959 | Myc target in myeloid cells-1, a novel c-Myc target, recapitulates multiple c-Myc phenotypes |
| Q35054858 | Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. |
| Q53380068 | Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. |
| Q28366366 | Myc/Max/Mad regulate the frequency but not the duration of productive cell cycles |
| Q28587989 | N-Myc and L-Myc are essential for hair cell formation but not maintenance |
| Q34830715 | N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development |
| Q36367230 | N-myc coordinates retinal growth with eye size during mouse development. |
| Q28207748 | N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation |
| Q55014166 | NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation. |
| Q28212421 | Negative regulation of the mammalian UV response by Myc through association with Miz-1 |
| Q37697114 | Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway |
| Q28590740 | Neural crest cell deficiency of c-myc causes skull and hearing defects |
| Q24681926 | Neuregulin3 alters cell fate in the epidermis and mammary gland |
| Q37995989 | New frontiers in cell competition |
| Q26826854 | Nodal signaling promotes a tumorigenic phenotype in human breast cancer |
| Q40666241 | Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing |
| Q36233025 | Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability |
| Q40555942 | Omomyc expression in skin prevents Myc-induced papillomatosis |
| Q33789149 | On the identification of potential regulatory variants within genome wide association candidate SNP sets |
| Q42321596 | Oncogenic regulation of tumor metabolic reprogramming |
| Q40200588 | PML4 induces differentiation by Myc destabilization |
| Q28508508 | PRELI (protein of relevant evolutionary and lymphoid interest) is located within an evolutionarily conserved gene cluster on chromosome 5q34-q35 and encodes a novel mitochondrial protein |
| Q42811126 | Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression |
| Q35570730 | Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics. |
| Q38336940 | Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation |
| Q44366709 | Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide |
| Q50692461 | Prognostic significance of MYCN gene amplification and protein expression in primary brain tumors: Astrocytoma and meningioma. |
| Q36216959 | Prognostic significance of Minichromosome maintenance protein 7 and Geminin expression in patients with 109 soft tissue sarcomas |
| Q33285211 | Proteome analysis of proliferative response of bystander cells adjacent to cells exposed to ionizing radiation |
| Q39658948 | Quantitative proteomic analysis of Myc oncoprotein function |
| Q73599437 | Quantitative proteomic analysis of chromatin-associated factors |
| Q53874874 | Recruitment of Gcn5-containing complexes during c-Myc-dependent gene activation. Structure and function aspects. |
| Q95811202 | Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer |
| Q34783510 | Regulation of N-myc expression in development and disease |
| Q40642721 | Regulation of c-myc gene by nitric oxide via inactivating NF-kappa B complex in P19 mouse embryonal carcinoma cells |
| Q28202238 | Repression of the TMEFF2 Promoter by c-Myc |
| Q40440846 | Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. |
| Q36143495 | Role of Src family kinases and N-Myc in spermatogonial stem cell proliferation. |
| Q34852828 | Runx transcription factors repress human and murine c-Myc expression in a DNA-binding and C-terminally dependent manner |
| Q33654212 | Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer |
| Q33193145 | Solution‐Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein–Protein or Protein–DNA Interactions |
| Q31157296 | Spatial distribution and function of sterol regulatory element-binding protein 1a and 2 homo- and heterodimers by in vivo two-photon imaging and spectroscopy fluorescence resonance energy transfer |
| Q33732822 | Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra |
| Q24810339 | Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays |
| Q39987298 | Suppression of C-myc expression associates with anti-proliferation of aloe-emodin on gastric cancer cells |
| Q40731052 | Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. |
| Q39029986 | TGF-β Family Signaling in the Control of Cell Proliferation and Survival |
| Q24298315 | TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC |
| Q36002496 | TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription |
| Q28281008 | Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells |
| Q36132771 | Targeting c-MYC in Platinum-Resistant Ovarian Cancer |
| Q52728139 | The MYC oncogene is a global regulator of the immune response. |
| Q89766642 | The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells |
| Q52655658 | The Myc trilogy: lord of RNA polymerases. |
| Q28295870 | The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60 |
| Q28575753 | The c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidase |
| Q37013896 | The c-myc promoter: still MysterY and challenge |
| Q39000409 | The human papillomavirus E7 oncoprotein as a regulator of transcription |
| Q52104498 | The protooncogene c-myc is an essential regulator of neural crest formation in xenopus. |
| Q38975478 | The role of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer |
| Q33924983 | The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster |
| Q37644952 | The ups and downs of Myc biology |
| Q35804087 | Thermal stress and the disruption of redox-sensitive signalling and transcription factor activation: possible role in radiosensitization |
| Q28190719 | Tissue-specific nuclear architecture and gene expression regulated by SATB1 |
| Q34932264 | Transcription factors as targets for cancer therapy |
| Q39048077 | Transcriptional control of DNA replication licensing by Myc. |
| Q36215755 | Transcriptional regulation and transformation by Myc proteins |
| Q24537716 | Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes |
| Q35082149 | Transcriptional repression by Myc. |
| Q24629916 | Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element |
| Q36162197 | Transforming growth factor-β activates c-Myc to promote palatal growth. |
| Q41208913 | Translation initiation by the c-myc mRNA internal ribosome entry sequence and the poly(A) tail. |
| Q40399589 | Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression |
| Q48424196 | WS5, a direct target of oncogenic transcription factor Myc, is related to human melanoma glycoprotein genes and has oncogenic potential. |
| Q33758260 | Whole-genome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes |
| Q91940275 | Writing and erasing MYC ubiquitination and SUMOylation |
| Q24316949 | c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene |
| Q37620912 | c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation |
| Q42115767 | c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle |
| Q28583514 | c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair |
| Q33925138 | c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium |
| Q35087557 | c-Myc regulates cell proliferation during lens development |
| Q28186628 | c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation |
| Q35222270 | c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. |
| Q47072112 | dMyc transforms cells into super-competitors |
| Q73642456 | jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression |
| Q24679145 | mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad |